BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12752569)

  • 1. APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men.
    Baum L; Tomlinson B; Thomas GN
    Clin Genet; 2003 May; 63(5):377-9. PubMed ID: 12752569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
    Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
    Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
    Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
    BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
    Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
    Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
    Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
    Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
    PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia.
    Evans D; Buchwald A; Beil FU
    J Mol Med (Berl); 2003 Oct; 81(10):645-54. PubMed ID: 12937897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.
    Pennacchio LA; Rubin EM
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):529-34. PubMed ID: 12615678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks.
    Hodoglugil U; Tanyolaç S; Williamson DW; Huang Y; Mahley RW
    J Lipid Res; 2006 Jan; 47(1):144-53. PubMed ID: 16258166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
    Liu ZK; Hu M; Baum L; Thomas GN; Tomlinson B
    Atherosclerosis; 2010 Feb; 208(2):427-32. PubMed ID: 19732897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
    Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
    Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
    Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
    Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
    Yan SK; Cheng XQ; Song YH; Xiao XH; Bi N; Chen BS
    Clin Chem Lab Med; 2005; 43(6):607-12. PubMed ID: 16006256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.
    Pennacchio LA; Olivier M; Hubacek JA; Krauss RM; Rubin EM; Cohen JC
    Hum Mol Genet; 2002 Nov; 11(24):3031-8. PubMed ID: 12417524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
    Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
    Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.
    Talmud PJ; Cooper JA; Hattori H; Miller IP; Miller GJ; Humphries SE
    Diabetologia; 2006 Oct; 49(10):2337-40. PubMed ID: 16917759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.